Research & Development

For Your Healthy Life, NovMetaPharma

Research Areas & Achievements

NovMetaPharma is a company that specializes in developing first-in-class drugs. We focus on the development of medication for metabolic diseases such as diabetes, obesity, and chronic kidney disease.

NovMetaPharma is carrying out all stages of new drug development from discovery of the new drug candidates to GMP production, preclinical and clinical trials, new drug approval, and commercialization.

Program Target Products IP Strategy Country
Core substance-based medication Substance patent US (plus PCT international patent applications)
Diabetes medication NovDB2 Diabetes dosage patent Korea / USA (plus PCT international patent applications)
Compound medication patent Korea / USA / Europe / China / Hong Kong / Japan
NovAQ Single medication patent Korea / USA / Europe / China / Japan
Compound medication patent 1 Korea / USA / Europe / China / Hong Kong / Japan
Compound medication patent 2 Korea (plus PCT international patent applications)
Anti-obesity medication NovOB Obesity basic patent USA / England / Germany
Obesity dosage patent Korea (plus PCT international patent applications)
Liver and kidney medication NovRD Cell protection patent Korea / USA / Europe / China / Japan
Fibrosis medication NovFS Fibrosis prevention and improvement patent Korea (plus PCT international patent applications)
NovRF Retroperitoneal fibrosis prevention and treatment patent Korea (plus PCT international patent applications)
Inflammatory bowel disease medication NovIB inflammatory bowel disease treatment and prevention patent USA (plus PCT international patent applications)
Viral disease medication Nov19 Antiviral patent USA (plusPCT international patent applications)
Vascular disease medication NovAS Arteriosclerosis patent USA (plus PCT international patent applications)
NovBP Blood pressure drop patent Korea (plus PCT international patent applications)
Bone loss disease medication NovHO Osteoporosis patent Korea (plus PCT international patent applications)
NovOS Osteoporosis patent Korea / USA / Europe / China / Japan
Osteoporosis compound medication patent Korea (plus PCT international patent applications)
Antithrombotic and female menopause medication NovBH Antithrombotic patent Korea / USA / Europe / China / Japan
NovWH Female menopause patent Korea
Cognitive impairment medication NovCO Cognitive impairment prevention and improvement patent Korea (plus PCT international patent applications)
Alzheimer’s disease medication NovAD AD basic patent Korea / USA
Dopamine patent Korea
Acute pancreatitis medication NovAP Acute pancreatitis use patent USA (plus PCT international patent applications)
Degenerative brain disease medication NovGP Degenerative brain disease patent 1 Korea (plus PCT international patent applications)
NovHB Degenerative brain disease patent 2 Korea (plus PCT international patent applications)
Liver cancer medication NovLC Liver cancer use patent Korea (plus PCT international patent applications)
Cytokine inhibitor NovCK Cytokine inhibition patent USA (plus PCT international patent applications)
Exercise performance enhancement NovGR Exercise performance enhancement compound medication patent Korea / USA / China
NovMR Exercise performance enhancement patent USA / Japan
NovMetaHealth